SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000769993-08-000650
Filing Date
2008-04-10
Accepted
2008-04-10 10:14:59
Documents
1
Group Members
GS INVESTMENT STRATEGIES, LLC

Document Format Files

Seq Description Document Type Size
1 amylinpharmaceuticalsinc.txt SC 13G 16575
  Complete submission text file 0000769993-08-000650.txt   18353
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42168 | Film No.: 08748978
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address 32 OLD SLIP NEW YORK NY 10005
GOLDMAN SACHS ASSET MANAGEMENT LP (Filed by) CIK: 0001229262 (see all company filings)

IRS No.: 000000000
Type: SC 13G